NASDAQ:CBUS Cibus (CBUS) Stock Price, News & Analysis $1.13 +0.04 (+3.67%) Closing price 11/13/2026 04:00 PM EasternExtended Trading$1.13 0.00 (0.00%) As of 11/13/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About Cibus Stock (NASDAQ:CBUS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cibus alerts:Sign Up Key Stats Today's Range$1.02▼$1.1450-Day Range$1.09▼$1.7152-Week Range$1.02▼$4.19Volume148,182 shsAverage Volume84,857 shsMarket Capitalization$86.37 millionP/E RatioN/ADividend YieldN/APrice Target$9.00Consensus RatingHold Company Overview Cibus is an agricultural technology company that develops plant traits using gene-editing technologies. Its proprietary Rapid Trait Development System (RTDS) is designed to make precise changes to a plant’s own genes, with the goal of developing useful crop characteristics without adding foreign DNA. The company’s research and development focuses on traits for crops including canola, rice and wheat, such as herbicide tolerance and resistance to crop diseases. Cibus aims to bring these traits to market through seed and technology licensing arrangements with partners in the agricultural industry. Cibus was formed in 2023 through a business combination involving Cibus Global and Calyxt, a plant-based gene-editing company. The company is headquartered in San Diego, California, and is led by co-founder Rory Riggs, who serves as its chairman and chief executive officer.AI Generated. May Contain Errors. Read More Cibus Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks31st Percentile Overall ScoreCBUS MarketRank™: 1.541298906595 of 5 starsCibus scored higher than 31% of companies evaluated by MarketBeat, and ranked 770th out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingCibus has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialCibus has a consensus price target of $9.00, representing about 696.5% upside from its current price of $1.13.Amount of Analyst CoverageCibus has only been the subject of 1 research reports in the past 90 days.Read more about Cibus' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Cibus are expected to grow in the coming year, from ($1.13) to ($1.07) per share.Price to Book Value per Share RatioCibus has a P/B Ratio of 2.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.75% of the float of Cibus has been sold short.Short Interest Ratio / Days to CoverCibus has a short interest ratio ("days to cover") of 61.82, which indicates bearish sentiment.Change versus previous monthShort interest in Cibus has recently decreased by 1.42%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCibus does not currently pay a dividend.Dividend GrowthCibus does not have a long track record of dividend growth. News and Social Media1.0 / 5News Sentiment-0.43 News SentimentCibus has a news sentiment score of -0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Cibus this week, compared to 3 articles on an average week. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cibus insiders have not sold or bought any company stock.Percentage Held by Insiders29.91% of the stock of Cibus is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions33.81% of the stock of Cibus is held by institutions.Read more about Cibus' insider trading history. Receive CBUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cibus and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CBUS Stock News HeadlinesCibus (CBUS) Q3 2026 Earnings Call TranscriptNovember 13 at 3:01 PM | finance.yahoo.comCibus, Inc. (CBUS) Q3 2026 Earnings Call TranscriptNovember 12 at 11:00 PM | seekingalpha.comDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.November 15 at 1:00 AM | Weiss Ratings (Ad)Cibus Reports Third Quarter Financial Results and Provides Business UpdateNovember 12 at 4:05 PM | globenewswire.comCibus Q3 2026 earnings previewNovember 11, 2026 | msn.comCibus Inc (CBUS) Q3 2026 Earnings Report Preview: What To Look ForNovember 11, 2026 | finance.yahoo.comCibus to Report Third Quarter 2026 Financial Results on November 12, 2026 After the Market Close and Host Conference CallNovember 3, 2026 | globenewswire.comCibus and Crystal Crop Protection Team Up to Improve India’s Mustard CropSeptember 29, 2026 | finance.yahoo.comSee More Headlines CBUS Stock Analysis - Frequently Asked Questions How have CBUS shares performed this year? Cibus' stock was trading at $1.74 at the start of the year. Since then, CBUS shares have decreased by 35.1% and is now trading at $1.13. How were Cibus' earnings last quarter? Cibus, Inc. (NASDAQ:CBUS) announced its quarterly earnings results on Thursday, November, 12th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by $0.09. The business earned $800 thousand during the quarter, compared to the consensus estimate of $1.30 million. Cibus had a negative net margin of 2,131.38% and a negative trailing twelve-month return on equity of 526.66%. Read the conference call transcript. When did Cibus IPO? Cibus (CBUS) raised $63 million in an initial public offering on Thursday, July 20th 2017. The company issued 7,000,000 shares at $8.00-$10.00 per share. Morgan Stanley, BofA Merrill Lynch and Piper Jaffray served as the underwriters for the IPO. Who are Cibus' major shareholders? Cibus' top institutional investors include State Street Corp (0.21%), Capital Advisor Network LLC (0.12%), Prescott Group Capital Management L.L.C. (0.11%) and StoneX Group Inc. (0.04%). Insiders that own company stock include Gregory Francis William Gocal, Noel Sauer, Carlo Broos and Gerhard Prante. View institutional ownership trends. How do I buy shares of Cibus? Shares of CBUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cibus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cibus investors own include Applied Digital (APLD), NVIDIA (NVDA), Archer Aviation (ACHR), Pfizer (PFE), Applied Optoelectronics (AAOI), Arcutis Biotherapeutics (ARQT) and Coinbase Global (COIN). Company Calendar Last Earnings11/12/2026Today11/15/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 13 days, CBUS's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:CBUS Previous SymbolNASDAQ:CBUS CIK1705843 Webwww.cibus.com Phone(858) 450-0008FaxN/AEmployees118Year Founded2001Price Target and Rating Average Price Target for Cibus$9.00 High Price Target$15.00 Low Price Target$3.00 Potential Upside/Downside+696.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($1.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$127.08 million Net Margins-2,131.38% Pretax Margin-2,145.48% Return on Equity-526.66% Return on Assets-28.12% Debt Debt-to-Equity RatioN/A Current Ratio0.95 Quick Ratio0.95 Sales & Book Value Annual Sales$3.64 million Price / Sales23.73 Cash FlowN/A Price / Cash FlowN/A Book Value$0.40 per share Price / Book2.83Miscellaneous Outstanding Shares76,430,000Free Float53,569,000Market Cap$86.37 million OptionableOptionable Beta1.65 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:CBUS) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment t...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cibus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cibus With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.